Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 7,810,000 | 8,259,000 | 8,191,000 | 7,775,000 | 7,729,000 |
| Cost of Goods | 2,316,000 | 2,296,000 | 2,074,000 | 2,031,000 | 2,233,000 |
| Gross Profit | 5,494,000 | 5,963,000 | 6,117,000 | 5,744,000 | 5,496,000 |
| Operating Expenses | 4,654,000 | 3,776,000 | 3,966,000 | 3,589,000 | 4,036,000 |
| Operating Income | 840,000 | 2,187,000 | 2,151,000 | 2,155,000 | 1,460,000 |
| Interest Expense | 138,000 | 115,000 | 111,000 | 103,000 | 99,000 |
| Other Income | -558,000 | -485,000 | -115,000 | -109,000 | -149,000 |
| Pre-tax Income | 144,000 | 1,587,000 | 1,925,000 | 1,943,000 | 1,212,000 |
| Income Tax | -96,000 | 364,000 | 484,000 | 490,000 | 137,000 |
| Net Income Continuous | 457,000 | 1,508,000 | 1,681,000 | 1,689,000 | 5,364,000 |
| Net Income Discontinuous | 34,000 | 154,000 | 95,000 | 103,000 | N/A |
| Minority Interests | -54,000 | -53,000 | -69,000 | -78,000 | -80,000 |
| Net Income | $437,000 | $1,609,000 | $1,707,000 | $1,714,000 | $1,209,000 |
| EPS Basic Total Ops | 0.34 | 1.23 | 1.31 | 1.31 | 0.92 |
| EPS Basic Continuous Ops | 0.34 | 1.23 | 1.31 | 1.31 | 0.92 |
| EPS Diluted Total Ops | 0.33 | 1.23 | 1.30 | 1.31 | 0.92 |
| EPS Diluted Continuous Ops | 0.31 | 1.23 | 1.23 | 1.31 | 0.92 |
| EBITDA(a) | $1,563,000 | $2,581,000 | $2,990,000 | $2,894,000 | $2,161,000 |